Baylor College of Medicine

NSABP B-59: Neoadjuvant Chemotherapy with Atezolizumab or Placebo for Triple Negative Breast Cancer (H-45197)

Description

Content

This study is being done to determine if the addition of atezolizumab to chemotherapy (weekly paclitaxel plus carboplatin followed by AC) improves response in the breast and lymph nodes (assessed pathologically at surgery) in patients with triple-negative breast cancer.

Contact

Cristina Coronel

Phone 1: 713–798–1975

IRB: H-45197

Status:

Active

Created:

Back to topback-to-top